Reducing securities exposed to market-value fluctuation risk
First written in FY2017-Q1. 12 of 13 entries say "Advanced", first in FY2017-Q2. Latest entry: FY2026.
2 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「This was attributable to the sale of 2 domestic shares among the investment securities held by the company.」
Regarding the reduction of strategically held shares, the company sold 2 domestic shares during the fiscal year and recorded sales proceeds of ¥94 million and a gain on sale of ¥58 million. - FY2023AdvancedAnnual report
「This was attributable to the sale of 5 domestic shares among the investment securities held by the company.」
The company sold 5 strategically held shares and recorded a gain on the sale of investment securities of ¥632 million. It continued reducing securities exposed to market-value fluctuation risk. - FY2023-Q3AdvancedAnnual report
「This was attributable to a decrease in investment securities following a reduction in accounts receivable and the sale of strategically held shares, while inventories increased as a result of higher production.」
The balance of investment securities decreased from ¥6,335 million at the end of the previous fiscal year to ¥5,708 million following the sale of strategically held shares, and the reduction of securities holdings continued. - FY2022-Q3AdvancedAnnual report
「Gain on sale of investment securities: ¥3,249 million」
The company recorded a gain on the sale of investment securities of ¥3,249 million through the sale of strategically held shares and other securities, advancing the reduction of its held securities. - FY2022-Q1AdvancedAnnual report
「At a Board of Directors meeting held on 25 February 2021, the company decided to review its strategically held shares under the Corporate Governance Code with the aim of improving the efficiency of its held assets and strengthening its financial position. It subsequently decided to sell the 3 investment securities it held and sold them between 9 and 30 July 2021. As a result, a gain on the sale of investment securities of ¥229 million will be recorded as extraordinary income in the second quarter of the fiscal year ending March 2022.」
The company sold 3 strategically held shares in July 2021 and planned to record a gain on sale of ¥229 million. - FY2021AdvancedAnnual report
「At a Board of Directors meeting held on 25 February 2021, the company decided to review its strategically held shares under the Corporate Governance Code with the aim of improving the efficiency of its held assets and strengthening its financial position. It subsequently sold the 10 investment securities it held between 5 April and 11 June 2021.」
Regarding the reduction of strategically held shares, the company decided to sell 10 securities and carried out the sales between April and June 2021. - FY2021-Q3AdvancedAnnual report
「Gain on sale of investment securities: ¥152 million」
The company recorded a gain on the sale of investment securities of ¥152 million and carried out a reduction of securities exposed to market-value fluctuation risk. - FY2019-Q3AdvancedAnnual report
「Gain on sale of investment securities: ¥188 million」
The company recorded a gain on the sale of investment securities of ¥188 million, and the balance of investment securities also decreased from the end of the previous fiscal year, resulting in continued progress in reducing securities exposed to market-value fluctuation risk. - FY2018AdvancedAnnual report
「Proceeds from the sale of investment securities: ¥528 million」
The company sold ¥528 million of investment securities and continued reducing securities exposed to market-value fluctuation risk. - FY2017AdvancedAnnual report
「Proceeds from the sale of investment securities: ¥2,363 million」
During the fiscal year, the company sold ¥2,363 million of investment securities and continued reducing securities exposed to market-value fluctuation risk. - FY2017-Q3AdvancedAnnual report
「Gain on sale of investment securities: ¥1,745 million」
In the cumulative third quarter of the current consolidated fiscal year, the company recorded a gain on the sale of investment securities of ¥1,745 million, while the balance of investment securities decreased from ¥20,120 million at the end of the previous consolidated fiscal year to ¥19,033 million. The reduction of securities exposed to market-value fluctuation risk continues. - FY2017-Q2AdvancedAnnual report
「Proceeds from the sale of investment securities of ¥1,965 million and expenditures for the acquisition of property, plant and equipment of ¥2,214 million, among other factors, resulted in cash flow from investing activities of ¥387 million used, a decrease in expenditures of ¥1,120 million from the cumulative second quarter of the previous fiscal year.」
The company sold ¥1,965 million of investment securities, taking concrete steps to reduce its securities holdings. - FY2017-Q1First statedAnnual report
「To address the market-value fluctuation risk of securities resulting from movements in securities markets, the company will continue reducing securities exposed to such risk.」
As a measure to address market-value fluctuation risk in held securities, the company has for the first time explicitly stated that it will reduce the securities concerned.